USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Search results for: 'Diversity and inclusive'
- Did you mean
- diversif and inclusive
- diversity ad inclusive
- Related search terms
- Android EDC POS terminal forecast 2024
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (1509=3753) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,1509) END) FROM DUAL) IS NULL-- wUvH
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
-
13 May 2021 | Global | Market Research
Post-COVID-19 Trends Disrupt the Global Contract Research Organization (CRO) Market
Increased Focus on Patient Centricity and Diversity in Clinical Trials Provide Growth Opportunities for CROs and Technology Vendors
Frost & Sullivan presents post-COVID-19 growth opportunities and strategic imperatives in the contract research organization (CRO) market, covering the markets maturity, key participants, competitive landscape, and recent mergers and acquisitions. The study highlights key growth drivers and restraints, identifies initiatives by major global CROs, a...
$4,950.00
Special Price $3,712.50 save 25 %
-
30 Dec 2022 | Global | Market Research
Growth Opportunities in Global Pharmaceutical Logistics
Cold chain Investments and Hybrid Clinical Trials to Ensure Transformational Growth of Pharmaceutical Logistics
Medicine production supply chains are currently operating under huge stress due to the war in Ukraine, COVID-19-related disruptions, logistics bottlenecks, and inflation. An energy-related shutdown of production would have a detrimental effect on the supply of critical medicines to patients in the EU and worldwide. The excessive amount of pressure ...
$2,450.00
Special Price $1,837.50 save 25 %
-
08 Mar 2022 | North America | Market Outlook
Global Pharmaceuticals Outlook, 2022
The Digitalization of the Pharmaceuticals Value Chain is Opening up New Growth Opportunities for Stakeholders
Frost & Sullivan offers an outlook for the global pharmaceuticals market for 2022-2026, including emerging trends and growth opportunities. Prioritizing booster doses over initial dose coverage is negatively impacting the global mitigation of the COVID-19 pandemic, which is resulting in severe implications on health and social and economic well-bei...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Sep 2022 | Global | Technology Research
Technology Growth Opportunities for Exosome-Mediated Drug Delivery
Exosomes Are Promising Delivery Carriers for Advanced Therapeutics
Exosome-mediated drug delivery is a promising alternative to conventional drug delivery methods, making rapid strides in the biopharmaceutical industry because of the safety and efficacy advantages exosomes offer as nanocarriers over synthetic nanoparticles. The widely explored concepts of nanomedicine, nucleic acid therapeutics, and cell-free vacc...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Apr 2023 | Asia Pacific | Market Outlook
Asia-Pacific Pharmaceutical Industry Outlook, 2023
Disruptive Technology Adoption and Outsourcing Growth is Advancing Innovation in the Pharmaceutical Industry
Asia-Pacific’s pharmaceutical market is forecast to record 4.2% growth from 2022 to 2027, with China and Japan dominating the market in terms of value. Generics dominate the regional markets based on volume, directly impacting innovator molecule uptake. Nevertheless, Asia-Pacific is establishing itself as a global innovation hub, with China, Japan,...
$4,950.00
Special Price $3,712.50 save 25 %
